Phio Pharmaceuticals Corp
General ticker "PHIO" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $2.6M
Phio Pharmaceuticals Corp does not follow the US Stock Market performance with the rate: -32.1%.
Estimated limits based on current volatility of 21.5%: low 1.74$, high 2.69$
Factors to consider:
- Current price 48.9% below estimated low
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2023-12-31 to 2025-12-30
- 2023-12-31 to 2024-12-30 estimated range: [4.37$, 14.12$]
- 2024-12-30 to 2025-12-30 estimated range: [2.93$, 8.48$]
Financial Metrics affecting the PHIO estimates:
- Negative: Non-GAAP EPS, $ of -52.69 <= 0.10
- Negative: Operating profit margin, % of -100 <= 1.03
- Negative: Operating cash flow per share per price, % of -84.90 <= 2.35
- Negative: negative Net income
- Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85
Short-term PHIO quotes
Long-term PHIO plot with estimates
Financial data
| YTD | 2021-12-31 | 2022-12-31 | 2023-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $13.51MM | $11.46MM | $10.82MM |
| Operating Income | $-13.51MM | $-11.46MM | $-10.82MM |
| Non-Operating Income | $0.22MM | $-0.02MM | $-0.00MM |
| R&D Expense | $8.89MM | $7.01MM | $6.33MM |
| Income(Loss) | $-13.29MM | $-11.48MM | $-10.83MM |
| Profit(Loss) | $-13.29MM | $-11.48MM | $-10.83MM |
| Stockholders Equity | $21.93MM | $10.84MM | $7.73MM |
| Assets | $25.17MM | $12.81MM | $9.36MM |
| Operating Cash Flow | $-11.86MM | $-12.13MM | $-10.75MM |
| Capital expenditure | $0.05MM | $0.12MM | $0.01MM |
| Investing Cash Flow | $-0.05MM | $-0.12MM | $-0.01MM |
| Financing Cash Flow | $21.72MM | $-0.03MM | $7.41MM |
| Earnings Per Share* | $-111.32 | $-89.61 | $-46.87 |
* EPS are Split Adjusted, recent splits may be reflected with a delay.